Matches in Library of Congress for { <http://lccn.loc.gov/2006938887> ?p ?o. }
Showing items 1 to 28 of
28
with 100 items per page.
- 2006938887 contributor B10747129.
- 2006938887 created "c2007.".
- 2006938887 date "2007".
- 2006938887 date "c2007.".
- 2006938887 dateCopyrighted "c2007.".
- 2006938887 description "Introduction: the rationale for the development of targeted drugs in cancer therapy -- Identifying critical signaling molecules for the treatment of cancer -- Tyrosine kinase inhibitors and cancer therapy -- Targeting ERBB receptors in cancer -- Inhibition of the IGF-I receptor for treatment of cancer. Kinase inhibitors and monoclonal anitbodies as alternative approaches -- Inhibition of the TGF-B signaling pathway in tumor cells -- The mammalian target of rapamycin kinase and tumor growth inhibtition -- The ras signalling pathway as a target in cancer therapy -- The mitogen-activated protein kinase pathway for molecular-targeted cancer treatment -- Clinical relevance of tareted interference with Src-mediated signal transduction events.".
- 2006938887 extent "ix, 188 p. :".
- 2006938887 identifier "3540312080 (hbk.)".
- 2006938887 identifier "9783540312086 (hbk.)".
- 2006938887 identifier 2006938887-d.html.
- 2006938887 identifier 2006938887-t.html.
- 2006938887 isPartOf "Recent results in cancer research ; v. 172".
- 2006938887 issued "2007".
- 2006938887 issued "c2007.".
- 2006938887 language "eng".
- 2006938887 publisher "Berlin ; New York : Springer,".
- 2006938887 subject "616.994061 22".
- 2006938887 subject "Cancer Chemotherapy.".
- 2006938887 subject "Cancer Gene therapy.".
- 2006938887 subject "Cell Communication physiology".
- 2006938887 subject "Neoplasms drug therapy".
- 2006938887 subject "Neoplasms physiopathology".
- 2006938887 subject "Neoplasms therapy".
- 2006938887 subject "RC271.C5 .T37 2007".
- 2006938887 subject "Signal Transduction physiology".
- 2006938887 tableOfContents "Introduction: the rationale for the development of targeted drugs in cancer therapy -- Identifying critical signaling molecules for the treatment of cancer -- Tyrosine kinase inhibitors and cancer therapy -- Targeting ERBB receptors in cancer -- Inhibition of the IGF-I receptor for treatment of cancer. Kinase inhibitors and monoclonal anitbodies as alternative approaches -- Inhibition of the TGF-B signaling pathway in tumor cells -- The mammalian target of rapamycin kinase and tumor growth inhibtition -- The ras signalling pathway as a target in cancer therapy -- The mitogen-activated protein kinase pathway for molecular-targeted cancer treatment -- Clinical relevance of tareted interference with Src-mediated signal transduction events.".
- 2006938887 title "Targeted interference with signal transduction events / B. Groner (ed.).".
- 2006938887 type "text".